BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — a leading precision medicine diagnostics company in transplant, specialty oncology, and cell therapy, today announced the company will participate in the following investor conferences:


Live and archived webcasts of the presentations will be available on the “Events and Presentations” section of the CareDx investor relations website at investors.caredx.com.
About CareDx
CareDx is a leading precision medicine diagnostics company advancing care in transplant, specialty oncology, and cell therapy. Through non-invasive longitudinal molecular biomarker testing, digital health, and patient support solutions, CareDx is dedicated to improving patient outcomes. For more information, please visit www.caredx.com.
CareDx, Inc.
Media
Natasha Moshirian Wagner
nwagner@CareDx.com
Investor Relations
Nina Deka
investor@CareDx.com
| Nov-20 | |
| Nov-09 |
ARK Invest Dumps These Shares While They're Hot, Buys Chips The Size Of Your Face
CDNA +7.46%
Investor's Business Daily
|
| Nov-06 | |
| Nov-03 | |
| Oct-29 | |
| Oct-29 | |
| Oct-29 | |
| Oct-22 | |
| Oct-21 | |
| Oct-15 | |
| Sep-24 | |
| Aug-07 | |
| Aug-03 | |
| Jul-31 | |
| Jul-31 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite